No profile data available.
BioLife Solutions, Inc. (BLFS) is a healthcare company in the biological analysis equipment industry, based in Bothell, United States, with about 155 full-time employees.
It reported revenue of $96.21 million for fiscal year 2025, up 17.0% from fiscal year 2024, and net income of -$4.60 million. United States was its largest region in fiscal year 2025, with 80% of revenue. Its market capitalization was $1.89 billion as of October 5, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of October 5, 2026.
BioLife Solutions, Inc. develops, manufactures, and markets bioproduction products and services for the cell and gene therapy (CGT) industry in the United States, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies.
BioLife Solutions reported $96.21 million in revenue for fiscal year 2025, up 17.0% from $82.25 million in fiscal year 2024.
United States: 80% of revenue by region in fiscal year 2025, followed by Europe, Middle East, Africa (14%).
$1.89 billion as of October 5, 2026.
Listed companies of a similar size in the same industry (biological analysis equipment) include Bruker Corporation (BRKR), Neogen Corporation (NEOG), 10x Genomics, Inc. (TXG), Pacific Biosciences of California, Inc. (PACB).